GlassScriptPhysician profile
Mary Beth Miller
NPI 1891757563
$1,834.42
in general payments reported to CMS, 2019-2025
19 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $90.02 · 2021: $202 · 2022: $198 · 2023: $543 · 2024: $223 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,019.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $399.98 | 2019-2024 | |
| Exeltis, USA INC. | $260.62 | 2023 | Slynd |
| Astellas Pharma US INC | $252.30 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $164.16 | 2023-2025 | |
| Therapeuticsmd, INC. | $110.98 | 2019-2022 | |
| Exact Sciences Corporation | $109.43 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $70.31 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $64.74 | 2019-2022 | |
| Coopersurgical, INC. | $61.79 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Myovant Sciences INC. | $56.43 | 2021-2022 | |
| Agile Therapeutics, INC. | $55.71 | 2021-2022 | |
| Lupin INC. | $52.45 | 2019-2020 | |
| Sage Therapeutics, LLC | $38.86 | 2024 | |
| Pfizer INC. | $35.53 | 2023 | |
| Daiichi Sankyo INC. | $32.66 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26.05 | 2019 | |
| Covidien LP | $17.00 | 2020 | |
| Mylan Pharmaceuticals INC. | $13.16 | 2020 | |
| Allergan, INC. | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Beth Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.